SCHEMBL20276014

SCHEMBL20276014

CCc1cc2c(cc1CC)OC(C)(C)O2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.62
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALOX15 P16050 2/20 0.35
ALOX12 P18054 2/20 0.35
KIF11 P52732 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7519328 0.78 TSHR (1.00) TSHRCYP1A2CYP2C9CYP2C19ALOX15
SCHEMBL9588776 0.73 ALOX15 (0.53) TSHRCYP1A2CYP2C9CYP2C19L3MBTL1
SCHEMBL17171671 0.73 TSHR (0.77) TSHRCYP1A2CYP2C9CYP2C19ALOX15
SCHEMBL21133255 0.70 TSHR (0.72) TSHRCYP1A2CYP2C9CYP2C19ALOX15
SCHEMBL12681552 0.70 ALDH1A1 (0.46) TSHRTDP1L3MBTL1HTT
SCHEMBL21709189 0.69 TSHR (0.42) TSHRTDP1L3MBTL1
SCHEMBL24910672 0.69 TSHR (0.46) TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL6436185 0.69 MAPT (0.46) TSHRCYP1A2CYP2C9CYP2C19TDP1
SCHEMBL23462244 0.68 P2RX7 (0.41) TSHRKIF11
SCHEMBL29975759 0.68 P2RX7 (0.41) TSHRKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180170943-A1 PIPERIDINE DERIVATIVE AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2018-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180170943-A1 PIPERIDINE DERIVATIVE AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF GPER1, CYP19A1, PGR TSHR 403/4885CYP1A2 43/4885CYP2C9 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.